Dr. Ludovic Vallier, a leading expert in stem cells from the Berlin Institute of Health, shares groundbreaking insights into liver organogenesis. He discusses modeling non-alcoholic fatty liver disease and how his lab transitioned to researching SARS-CoV-2 during the pandemic. Vallier explains the potential of induced pluripotent stem cells (iPSCs) for liver regeneration after injury. The conversation also sheds light on the innovative therapies being developed for liver diseases and the collaboration happening within Germany's scientific community.